TD Cowen Insights

TD Securities, TD Cowen
undefined
Sep 25, 2025 • 40min

Powering the Future - How a Global Energy Leader Creates Value with a Diverse Asset Portfolio

Recorded on 09/23/25.Northland Power is a large-scale developer and operator of renewable, battery storage, and gas-fired power, with 3.5 gigawatts of operating capacity and an additional 2.2 gigawatts under construction. President and CEO Christine Healy provides a detailed overview of the company's diverse platform and compelling growth prospects across technologies and regions. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 17, 2025 • 36min

Decoding Sephora with Beauty Advisory, View From 32

Recorded on 08/01/25How to Succeed in Sephora & Drive Longevity. We host Cassie Cowman, Co-Founder of View from 32, who explains why Sephora launches demand 9-18 months of planning, aligned KPIs, and flawless execution. We discuss Rare Beauty’s blush and Rhode’s lip as lessons in category ownership and highlight haircare’s styling wave. We also unpack how biotech + AI are key drivers amid rising market volatility and Ulta vs. Sephora dynamics.What's Next in Beauty and Wellness and What Will Work For the Long Term. In this episode, Cassie explains that longevity in beauty comes from owning categories and building replenishable hero SKUs, not chasing viral spikes, and highlights how Rare Beauty’s dominance in blush and Rhode’s lip play serve as case studies in the trade-offs between loyalty and virality. The discussion unpacks haircare’s next wave in styling, biotech and AI-driven skincare innovation, and the rise of “expert-led” brands driving category engagement. Cassie also contrasts Sephora’s disciplined brand-building with Ulta’s broader assortment, arguing that Ulta must sharpen curation, education, and services to compete in a market where consumer demand is more volatile than ever. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 11, 2025 • 32min

Getting to know Zip, a major BNPL/POS financing provider

Recorded on 09/05/25In this episode, TD Cowen's Consumer Finance analyst Moshe Orenbuch hosts Zip Co CEO Cynthia Scott to explore what Zip does and its value proposition to consumers and merchants. We believe this is very relevant to our coverage of consumer finance companies including Affirm, given the fast growing BNPL industry in the U.S., competitive landscape, as well as Klarna's recent IPO. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 10, 2025 • 31min

Deploying Private Equity In Biotech

Recorded on 09/04/25TD Cowen analyst Yaron Werber speaks with Ricky Sun about Bain Capital's collaborative edge with both the Life Sciences and Private Equity teams, their broader Asia strategy with a focus on Japan and China, advice for biotech CEOs and boards, and opportunities and challenges in the current life sciences investing landscape. Ricky shares his learnings from Bain’s recent carve-out/taking private of Mitsubishi Tanabe Pharma (valued at roughly $3.3B), and notably how leveraging deep scientific and operational expertise across the Life Sciences and Japanese Private Equity teams was crucial for deal execution. In what is one of the key underpinnings of this deal, he shares optimism that the streamlining of drug approvals within the Japanese PMDA, especially for orphan indications, will allow faster time to market, reduce requirements to conduct Ph1 studies in Japanese patients by employing data from Western patients, and facilitate earlier feedback to sponsors, which will expedite approvals. He also cites his experience from >80 deals that suggests that quality of management, sound decision making, and discipline in capital deployment are the key factors for success in biotech. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 8, 2025 • 11min

Tokenization of Equity Trading; Financial Policy Schedule For September

Recorded on 09/04/25 TD Cowen financial policy analyst Jaret Seiberg hosts TD Cowen's Two Cents Podcast, which includes a discussion of tokenized equity trading with Reid Noch, who follows U.S. market structure at TD Cowen. We also get a market update from Scott Smith, the TD Cowen specialty salesperson for financials. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 2, 2025 • 26min

Cracking the Clinical Trial Code with ConcertAI's Jeff Elton

Recorded on 06/23/25TD Cowen's Machine Medicine: AI & Health Care podcast series takes on the cross-sector revolution in artificial intelligence and breaks it down one piece at a time. We highlight some of the biggest misconceptions about how AI is and can be used in different health care settings and aim to contextualize the latest and most significant developments in a field defined by rapid innovation.  In this episode, TD Cowen's health care analyst Brendan Smith hosts Jeff Elton, Vice Chairman of ConcertAI, to explore how ConcertAI is rewriting the playbook for designing and enrolling clinical trials using AI and data-driven precision. We discuss how ripe the current process of running clinical trials is for this kind of innovation as well as how recent guidance from the FDA is shifting conversations with customers. We also aim to unpack what the path toward widespread AI integration could look like and where the field may go from here, especially as the push for faster and more precise trials continues to be a top priority for the entire health care sector.   https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Sep 2, 2025 • 44min

Biotech Beauty + Skin Longevity Featuring AV Laboratories CEO/CMO

Recorded on 07/30/25Stem Cells To Skin: How Molecular Biology & AV Laboratories' SOM3 Molecule Drive Skin Wellness. We host AV Laboratories CEO Ami Mezezi and CMO Josh Smith to discover how they merge biotechnology and regenerative science with efficacious skincare. AV Laboratories is a biotech company first, differentiated by full vertical integration: developing, testing, and manufacturing all in-house. SOM3 is AV Laboratories' proprietary molecular nutrition system that delivers targeted amino acids and cofactors to support cell metabolism and longevity. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Aug 29, 2025 • 46min

Race To The Finish Line – Catalysts Into Year End

Recorded on 08/28/2025 In this episode, Roman Schweizer, TD Cowen’s WRG geopolitics & defense analyst, discusses the big must-do things in Washington and potential catalysts through the end of the year with an All-Star reporter lineup. We cover recent Administration comments about the Federal Government taking equity positions in defense companies and look at upcoming issues such as the FY26 National Defense Authorization Act, appropriations, Continuing Resolutions, shutdown risk, rescissions, plus some program milestones on General Atomics' Collaborative Combat Aircraft, Northrop Grumman's B-21 and SpaceX's Starship. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Aug 20, 2025 • 23min

QTS Co-CEO Tag Greason On The Data Center Outlook

Recorded on 08/12/25We spoke with QTS's Co-CEO Tag Greason at TD Cowen's 11th Annual Communications Infrastructure Summit. Mr. Greason discusses the evolution of QTS since being taken private by Blackstone in 2021, the state of hyperscale AI demand, and the bottlenecks for data center capacity delivery. In addition, Mr. Greason highlights his observations of the enterprise data center market, trends for data center development yields, and lessons from prior infrastructure buildout cycles.   https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
undefined
Aug 19, 2025 • 32min

Unlock Your Tripeptide Glow With Allies of Skin's CEO

Recorded on 07/09/25From Trauma to Transformation, the Future Is Regenerative Skincare. Nicolas Travis intimately shares how failed facial reconstruction surgeries at 19 inspired him to build Allies of Skin, a global brand rooted in clinical science. Nicolas' mission is to make science-backed skincare more human and accessible for all skin journeys using regenerative actives including growth factors and peptides.How Recovery Inspired Allies of Skin's Regenerative Approach. In this episode, Nicolas Travis, CEO/Founder of Allies of Skin, highlights how the brand combines rigorous science with a deeply human approach to beauty. He details how he launched Allies of Skin with three science-backed products, including the Peptides & Antioxidants Advanced Firming Daily Treatment (which is still their #1 best-selling moisturizer today), the Retinal & Peptides Advanced Repair Night Cream, and the Molecular Saviour Probiotics Treatment Mist. Travis explains how he then introduced the breakthrough Multi Peptides & Growth Factor Advanced Lifting Serum, a $188 hero product that took five years to create and has sold out seven times with a 12,000-person waitlist. Nicolas discusses how growth factors and peptides act as “personal trainers for your skin,” strengthening collagen and cellular communication. Travis also shares how Allies validates every launch through 28- and 56-day clinical studies and is now advancing into custom exosome delivery for 40x deeper ingredient penetration. We explore how Allies of Skin has scaled to 36 countries in nine years, driving rapid growth across Amazon, direct-to-consumer, and Cult Beauty, while also expanding retail doors at Nordstrom, Neiman Marcus, and Violet Grey. Targeting mature customers with higher spending power and loyalty, Allies balances margin goals with accessibility, offering products like SPF at $45, and adopts a channel-agnostic philosophy, meeting consumers where they shop, from luxury retailers to TikTok Shop. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app